Cirrhosis related functionality characteristic of the fecal microbiota as revealed by a metaproteomic approach

BMC Gastroenterology

Volumn 16, Issue 1, 2016, Pages

  Wei, Xiao ^a   Jiang, Shan ^a   Chen, Yuye ^b   Zhao, Xiangna ^a   Li, Huan ^a   Lin, Weishi ^a   Li, Boxing ^a   Wang, Xuesong ^a   Yuan, Jing ^a   Sun, Yansong ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b The Hospital of Traditional Chinese Medicine   (China)

Author keywords

BCAA; Cirrhosis; Fecal microbiota; Metaproteome

Indexed keywords

BRANCHED CHAIN AMINO ACID; COENZYME A; PANTOTHENIC ACID;

ADULT; AMINO ACID SYNTHESIS; ARTICLE; CARBOHYDRATE METABOLISM; CHILD PUGH SCORE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FECES MICROFLORA; HIGH THROUGHPUT SCREENING; HUMAN; INTESTINE FLORA; LIQUID CHROMATOGRAPHY; LIVER CIRRHOSIS; METAPROTEOMICS; MIDDLE AGED; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; SPOUSE; TANDEM MASS SPECTROMETRY; FECES; FEMALE; MALE; METABOLISM; METAGENOME; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX;

AMINO ACIDS, BRANCHED-CHAIN; CARBOHYDRATE METABOLISM; COENZYME A; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; LIVER CIRRHOSIS; MALE; METAGENOME; MIDDLE AGED; PANTOTHENIC ACID; PROTEOMICS; SEVERITY OF ILLNESS INDEX; SPOUSES;

EID: 84990032834     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/s12876-016-0534-0     Document Type: Article

References (26)

1. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449:804-10.
2. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355-9.
3. Usami M, Miyoshi M, Yamashita H. Gut microbiota and host metabolism in liver cirrhosis. World J Gastroenterol. 2015;21:11597-608.
4. Garcia-Tsao G, Wiest R. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol. 2004;18:353-72.
5. Benten D, Wiest R. Gut microbiome and intestinal barrier failure--the "Achilles heel" in hepatology? J Hepatol. 2012;56:1221-3.
6. Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatol Baltim Md. 2011;54:562-72.
7. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut. 2008;57:1605-15.
8. Ram RJ, Verberkmoes NC, Thelen MP, Tyson GW, Baker BJ, Blake RC, et al. Community proteomics of a natural microbial biofilm. Science. 2005;308:1915-20.
9. Wilmes P, Bond PL. The application of two-dimensional polyacrylamide gel electrophoresis and downstream analyses to a mixed community of prokaryotic microorganisms. Environ Microbiol. 2004;6:911-20.
10. Hernández E, Bargiela R, Diez MS, Friedrichs A, Pérez-Cobas AE, Gosalbes MJ, et al. Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity. Gut Microbes. 2013;4:306-15.
11. Ferrer M, Martins dos Santos VAP, Ott SJ, Moya A. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut Microbes. 2014;5:64-70.
12. Kolmeder CA, de Been M, Nikkilä J, Ritamo I, Mättö J, Valmu L, et al. Comparative metaproteomics and diversity analysis of human intestinal microbiota testifies for its temporal stability and expression of core functions. PLoS One. 2012;7:e29913.
13. Klaassens ES, de Vos WM, Vaughan EE. Metaproteomics approach to study the functionality of the microbiota in the human infant gastrointestinal tract. Appl Environ Microbiol. 2007;73:1388-92.
14. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2006;1:2856-60.
15. Albrethsen J, Knol JC, Piersma SR, Pham TV, de Wit M, Mongera S, et al. Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. Mol Cell Proteomics MCP. 2010;9:988-1005.
16. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389-402.
17. Tatusov RL, Galperin MY, Natale DA, Koonin EV. The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucleic Acids Res. 2000;28:33-6.
18. Letunic I, Yamada T, Kanehisa M, Bork P. iPath: interactive exploration of biochemical pathways and networks. Trends Biochem Sci. 2008;33:101-3.
19. Yu NY, Wagner JR, Laird MR, Melli G, Rey S, Lo R, et al. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinforma Oxf Engl. 2010;26:1608-15.
20. Petersen TN, Brunak S, von Heijne G, Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Methods. 2011;8:785-6.
21. Wei X, Yan X, Zou D, Yang Z, Wang X, Liu W, et al. Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach. BMC Gastroenterol. 2013;13:175.
22. Bragulla HH, Homberger DG. Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia. J Anat. 2009;214:516-59.
23. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59-65.
24. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55:205-11.
25. Spry C, van Schalkwyk DA, Strauss E, Saliba KJ. Pantothenate utilization by Plasmodium as a target for antimalarial chemotherapy. Infect Disord Drug Targets. 2010;10:200-16.
26. Bernal V, Masdemont B, Arense P, Cánovas M, Iborra JL. Redirecting metabolic fluxes through cofactor engineering: Role of CoA-esters pool during L(-)-carnitine production by Escherichia coli. J Biotechnol. 2007;132:110-7.